Embio Medical AB is a Swedish medtech company pioneering advanced catheters for the most severe cancers. Backed by CathPrint’s e-Shaft technology and several patent-pending innovations, our first focus is pancreatic cancer, where our catheters are engineered to adapt to the pancreatic duct and deliver precision-targeted therapies to areas that are otherwise difficult to reach.
Our mission is to make cancer treatment safer, more targeted, and less invasive, through precision catheter-based therapies — starting with pancreatic cancer, one of the hardest cancers to treat today.
We believe that patients everywhere should have access to effective and minimally invasive therapies. Our goal is to change the outlook for cancers that currently leave patients with few options.
Learn more about us
Embio’s catheter is engineered to deliver safer, earlier, and more effective cancer treatment.
Extremely small diameter enables deep duct access.
Customisable positioning for precision therapy.
Ensures full tissue contact for effective treatment.
Supports IRE and ECT for versatile applications.
Interested in partnering, collaborating, or learning more? Get in touch.
Contact Us